Literature DB >> 9051746

Decreased trkA gene expression within basal forebrain neurons in Alzheimer's disease.

E J Mufson1, J M Li, T Sobreviela, J H Kordower.   

Abstract

In situ hybridization for TrkA mRNA was combined with quantitative optical densitometry to evaluate whether the expression of this gene is altered within cholinergic basal forebrain neurons (CBF) in Alzheimer's disease (AD). TrkA mRNA within individual nucleus basalis neurons was significantly reduced (66%) in AD cases relative to aged controls. Reverse transcription polymerase chain reaction quantitative analyses confirmed that TrkA mRNA levels decreased markedly in AD. In contrast, expression of the gene coding for for the low affinity p75NTR was not significantly altered in AD relative to aged controls. These data indicate that there is a selective defect in trkA gene expression in AD, supporting the hypothesis that the degeneration of CBF neurons seen in this disease results from impaired nerve growth factor trophic support.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9051746     DOI: 10.1097/00001756-199612200-00006

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  19 in total

1.  Nontropic actions of neurotrophins: subcortical nerve growth factor gene delivery reverses age-related degeneration of primate cortical cholinergic innervation.

Authors:  J M Conner; M A Darracq; J Roberts; M H Tuszynski
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-13       Impact factor: 11.205

2.  NF-kappa B signaling promotes both cell survival and neurite process formation in nerve growth factor-stimulated PC12 cells.

Authors:  E D Foehr; X Lin; A O'Mahony; R Geleziunas; R A Bradshaw; W C Greene
Journal:  J Neurosci       Date:  2000-10-15       Impact factor: 6.167

Review 3.  On the molecular basis linking Nerve Growth Factor (NGF) to Alzheimer's disease.

Authors:  Simona Capsoni; Antonino Cattaneo
Journal:  Cell Mol Neurobiol       Date:  2006-08-31       Impact factor: 5.046

Review 4.  Neurotrophin Signaling and Stem Cells-Implications for Neurodegenerative Diseases and Stem Cell Therapy.

Authors:  Subrata Pramanik; Yanuar Alan Sulistio; Klaus Heese
Journal:  Mol Neurobiol       Date:  2016-11-05       Impact factor: 5.590

5.  Ex vivo nerve growth factor gene transfer to the basal forebrain in presymptomatic middle-aged rats prevents the development of cholinergic neuron atrophy and cognitive impairment during aging.

Authors:  A Martínez-Serrano; A Björklund
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-17       Impact factor: 11.205

6.  Difference in toxicity of beta-amyloid peptide with aging in relation to nerve growth factor content in rat brain.

Authors:  T Fukuta; A Nitta; A Itoh; S Furukawa; T Nabeshima
Journal:  J Neural Transm (Vienna)       Date:  2001       Impact factor: 3.575

7.  Infusion of nerve growth factor (NGF) into kitten visual cortex increases immunoreactivity for NGF, NGF receptors, and choline acetyltransferase in basal forebrain without affecting ocular dominance plasticity or column development.

Authors:  M A Silver; M Fagiolini; D C Gillespie; C L Howe; M G Frank; N P Issa; A Antonini; M P Stryker
Journal:  Neuroscience       Date:  2001       Impact factor: 3.590

8.  Amyloid precursor protein-mediated endocytic pathway disruption induces axonal dysfunction and neurodegeneration.

Authors:  Wei Xu; April M Weissmiller; Joseph A White; Fang Fang; Xinyi Wang; Yiwen Wu; Matthew L Pearn; Xiaobei Zhao; Mariko Sawa; Shengdi Chen; Shermali Gunawardena; Jianqing Ding; William C Mobley; Chengbiao Wu
Journal:  J Clin Invest       Date:  2016-04-11       Impact factor: 14.808

9.  The common neurotrophin receptor p75NTR enhances the ability of PC12 cells to resist oxidative stress by a trkA-dependent mechanism.

Authors:  W Wang; K E Dow; R J Riopelle; G M Ross
Journal:  Neurotox Res       Date:  2001-10       Impact factor: 3.911

10.  Gene expression profiles of cholinergic nucleus basalis neurons in Alzheimer's disease.

Authors:  Elliott J Mufson; Scott E Counts; Stephen D Ginsberg
Journal:  Neurochem Res       Date:  2002-10       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.